Positron emission tomographic imaging of the serotonergic system and prediction of risk and lethality of future suicidal behavior

JAMA Psychiatry

Volumn 73, Issue 10, 2016, Pages 1048-1055

  Oquendo, Maria A ^a,b   Galfalvy, Hanga ^a,b   Sullivan, Gregory M ^c   Miller, Jeffrey M ^a,b   Milak, Matthew M ^a,b   Elizabeth Sublette, M ^a,b   Cisneros Trujillo, Sebastian ^a,b   Burke, Ainsley K ^a,b   Parsey, Ramin V ^d   John Mann, J ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Tonix Pharmaceuticals LLC   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE; CARBON 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; BENZYLAMINE DERIVATIVE; CARBON; N,N-DIMETHYL-2-(2-AMINO-4-CYANOPHENYLTHIO)BENZYLAMINE; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; FOLLOW UP; HUMAN; INSULA; LETHALITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MESENCEPHALON; OBSERVATIONAL STUDY; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; BENZYLAMINES; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED;

EID: 84997830721     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.1478     Document Type: Article

References (67)

1. van Heeringen K, Mann JJ. The neurobiology of suicide. Lancet Psychiatry. 2014;1(1):63-72.
2. Oquendo MA, Sullivan GM, Sudol K, et al. Toward a biosignature for suicide. Am J Psychiatry. 2014;171 (12):1259-1277.
3. Miller JM, Hesselgrave N, Ogden RT, et al. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol Psychiatry. 2013;74 (4):287-295.
4. Nye JA, Purselle D, Plisson C, et al. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging. Depress Anxiety. 2013;30(10):902-907.
5. Selvaraj S, Murthy NV, Bhagwagar Z, et al. Diminished brain 5-HT transporter binding in major depression: A positron emission tomography study with [11C]DASB. Psychopharmacology (Berl). 2011; 213(2-3):555-562.
6. Cannon DM, Ichise M, Rollis D, et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB: comparison with bipolar disorder. Biol Psychiatry. 2007;62(8):870-877.
7. Vang FJ, Ryding E, Trkman-Bendz L, van Westen D, Lindstr MB. Size of basal ganglia in suicide attempters, and its association with temperament and serotonin transporter density. Psychiatry Res. 2010;183(2):177-179.
8. SubletteME, Milak MS, Galfalvy HC, Oquendo MA, Malone KM, Mann JJ. Regional brain glucose uptake distinguishes suicide attempters from non-Attempters in major depression. Arch Suicide Res. 2013;17(4):434-447.
9. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry. 1996;153(2): 174-182.
10. Oquendo MA, Placidi GP, Malone KM, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry. 2003;60(1):14-22.
11. Leyton M, Paquette V, Gravel P, et al. alpha-[11C]Methyl-L-Tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol. 2006;16(3):220-223.
12. Sullivan GM, Oquendo MA, Milak M, et al. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder. JAMA Psychiatry. 2015;72(2):169-178.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
14. Miller JM, Hesselgrave N, Ogden RT, et al. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry. 2013;74(10):760-767.
15. Parsey RV, Ogden RT, Miller JM, et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry. 2010;68(2):170-178.
16. Parsey RV, Oquendo MA, Ogden RT, et al. Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry. 2006;59(2): 106-113.
17. FirstMB Sr, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P), Version 2.0. New York: Biometrics Research, New York State Psychiatric Institute; 1994.
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
19. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-771.
20. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: The Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47(2):343-352.
21. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1(2):131-139.
22. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957; 21(4):343-349.
23. Barratt ES. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 1965;16:547-554.
24. Oquendo MAHB, Mann JJ. Risk factors for suicidal behavior: The utility and limitations of research instruments. In: First MB, ed. Standardized Evaluation in Clinical Practice. Vol 22.Washington, DC: American Psychiatric Publishing; 2003:103-130.
25. Posner K, Oquendo MA, Gould M, Stanley B, DaviesM. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDAs pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007; 164(7):1035-1043.
26. Beck AT, Beck R, Kovacs M. Classification of suicidal behaviors, I: quantifying intent and medical lethality. Am J Psychiatry. 1975;132(3):285-287.
27. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, John Mann J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab. 2005;25 (7):785-793.
28. Parsey RV, Slifstein M, Hwang DR, et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab. 2000;20(7):1111-1133.
29. Parsey RV, Ogden RT, Mann JJ. Determination of volume of distribution using likelihood estimation in graphical analysis: elimination of estimation bias. J Cereb Blood Flow Metab. 2003;23 (12):1471-1478.
30. Ogden RT. Estimation of kinetic parameters in graphical analysis of PET imaging data. Stat Med. 2003;22(22):3557-3568.
31. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533-1539.
32. Ogden RT, Tarpey T. Estimation in regression models with externally estimated parameters. Biostatistics. 2006;7(1):115-129.
33. Riihimi K, Vuorilehto M, Melartin T, Haukka J, Isomets E. Incidence and predictors of suicide attempts among primary-care patients with depressive disorders: A 5-year prospective study. Psychol Med. 2014;44(2):291-302.
34. Boldrini M, Underwood MD, Mann JJ, Arango V. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res. 2008;42(6):433-442.
35. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression: postmortem evidence for decreased serotonin activity. J Neurosci. 1998;18 (18):7394-7401.
36. Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Mann JJ, Arango V. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuropsychopharmacol. 2012;15(4): 435-447.
37. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience. 2002;114(3):807-815.
38. Arango V, Underwood MD, Mann JJ. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res. 2002;136:443-453.
39. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre-And postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995; 688(1-2):121-133.
40. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study. Arch Gen Psychiatry. 1993;50(10):810-818.
41. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter, II: suicidal behavior. Mol Psychiatry. 2003;8(7):646-653.
42. Lopez de Lara C, Dumais A, Rouleau G, et al. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry. 2006;59(2):114-120.
43. Gey C, Allard P, Brnstr T, Spigset O. Radioligand binding to brain dopamine and serotonin receptors and transporters in Parkinsons disease: relation to gene polymorphisms. Int J Neurosci. 2012;122(3):124-132.
44. Kobiella A, Reimold M, Ulsher DE, et al. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: The roles of in vivo serotonin transporter expression and amygdala structure. Transl Psychiatry. 2011;1:e37.
45. Murthy NV, Selvaraj S, Cowen PJ, et al. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage. 2010;52(1):50-54.
46. Rhodes RA, Murthy NV, Dresner MA, et al. Human 5-HT transporter availability predicts amygdala reactivity in vivo. J Neurosci. 2007;27 (34):9233-9237.
47. Oquendo MA, Hastings RS, Huang YY, et al. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry. 2007; 64(2):201-208.
48. Parsey RV, Hastings RS, Oquendo MA, et al. Effect of a triallelic functional polymorphism of the serotonin-Transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry. 2006;163(1):48-51.
49. Shioe K, Ichimiya T, Suhara T, et al. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse. 2003;48(4):184-188.
50. Kalbitzer J, Frokjaer VG, Erritzoe D, et al. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 2009;45(2):280-285.
51. Reimold M, Smolka MN, Schumann G, et al. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J Neural Transm (Vienna). 2007;114(5):635-639.
52. Praschak-Rieder N, Kennedy J, Wilson AA, et al. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: A [(11)C] DASB positron emission tomography study. Biol Psychiatry. 2007;62(4):327-331.
53. Hjorth S, Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 1991;48 (18):1779-1786.
54. Kelly JS, Larkman P, Penington NJ, Rainnie DG, McAllister-Williams H, Hodgkiss J. Serotonin receptor heterogeneity and the role of potassium channels in neuronal excitability. Adv Exp Med Biol. 1991;287:177-191.
55. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry. 1997;41(2): 162-171.
56. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol. 2006;9(4):465-474.
57. Nordstr P, Samuelsson M, Asberg M, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav. 1994;24(1):1-9.
58. Baca-Garc E, Diaz-Sastre C, Basurte E, et al. A prospective study of the paradoxical relationship between impulsivity and lethality of suicide attempts. J Clin Psychiatry. 2001;62(7):560-564.
59. Parsey RV, Oquendo MA, Simpson NR, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 2002;954(2):173-182.
60. Doihara C, Kawanishi C, Yamada T, et al. Trait aggression in suicide attempters: A pilot study. Psychiatry Clin Neurosci. 2008;62(3):352-354.
61. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry. 2001;50(10):783-791.
62. Naqvi NH, Gaznick N, Tranel D, Bechara A. The insula: A critical neural substrate for craving and drug seeking under conflict and risk. Ann N Y Acad Sci. 2014;1316:53-70.
63. Evrard HC, Forro T, Logothetis NK. Von Economo neurons in the anterior insula of the macaque monkey. Neuron. 2012;74(3):482-489.
64. Joiner TE, Pettit JW, Walker RL, et al. Perceived burdensomeness and suicidality: Two studies on the suicide notes of those attempting and those completing suicide. J Soc Clin Psychol. 2002;21(5): 531-545.
65. Klein TA, Ullsperger M, Danielmeier C. Error awareness and the insula: links to neurological and psychiatric diseases. Front Hum Neurosci. 2013;7:14.
66. Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF, Gotlib IH. Functional neuroimaging of major depressive disorder: Ameta-Analysis and new integration of base line activation and neural response data.AmJ Psychiatry. 2012;169(7):693-703.
67. Hahn A, Wadsak W, Windischberger C, et al. Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci U S A. 2012;109(7):2619-2624.